News tagged with lymphoma
Microbiologists identify two molecules that kill lymphoma cells in mice
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Nov 06, 2011 |
5 / 5 (5) |
2
|
Study reveals how fusion protein triggers cancer
What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts.
Jan 27, 2011 |
4.3 / 5 (3) |
1
|
Humble protein, nanoparticles tag-team to kill cancer cells
(PhysOrg.com) -- A normally benign protein found in the human body appears to be able - when paired with nanoparticles - to zero in on and kill certain cancer cells, without having to also load those particles ...
Nanotechnology / Bio & Medicine
Jul 30, 2010 |
5 / 5 (5) |
0
|
Scientists find new way to attack cancerous cells
Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.
Jun 07, 2010 |
5 / 5 (11) |
0
|
'Junk DNA' drives cancer growth
Researchers from the University of Leeds, UK, the Charite University Medical School and the Max Delbruck Centre for Molecular Medicine (MDC) in Berlin, Germany, have discovered a new driving force behind cancer growth.
May 02, 2010 |
4.9 / 5 (12) |
4
|
New way to kill cancer found using body's immune system
(PhysOrg.com) -- Scientists have discovered a new way of killing cancer cells in a breakthrough that could eventually lead to new treatments for a range of different cancers.
Jul 21, 2009 |
5 / 5 (9) |
6
Jarid2 may break the Polycomb silence
Historically, fly and human Polycomb proteins were considered textbook exemplars of transcriptional repressors, or proteins that silence the process by which DNA gives rise to new proteins. Now, work by a ...
Apr 30, 2012 |
5 / 5 (1) |
0
|
Worm studies shed light on human cancers
(PhysOrg.com) -- Research in the worm is shedding light on a protein associated with a number of different human cancers, and may point to a highly targeted way to treat them.
Apr 21, 2011 |
not rated yet |
0
|
Pacific salmon may be dying from leukemia-type virus
In Canada's Fraser River, a mysterious illness has killed millions of Pacific salmon, and scientists have a new hypothesis about why: The wild salmon are suffering from viral infections similar to those linked to some forms ...
Apr 18, 2011 |
5 / 5 (3) |
3
Researchers predict age of T cells to improve cancer treatment
Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's ...
Mar 02, 2011 |
not rated yet |
0
|
Study shows how dietary supplement may block cancer cells
Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have discovered how a substance that is produced when eating broccoli ...
Jun 29, 2010 |
4 / 5 (17) |
0
|
Control of cancer cell pathways key to halting disease spread, study shows
Oncogenes are like friends who've gone off the deep end. Normally steady, reliable members of the cellular workforce, these genes become very bad influences when mutated or expressed at high levels -- urging a cell to divide ...
Jun 14, 2010 |
5 / 5 (1) |
0
|
A new target for lymphoma therapy
Researchers at the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI) have found a link between a common mutation that can lead to cancer and ...
Dec 09, 2009 |
not rated yet |
0
Researchers restore some function to cells from cystic fibrosis patients
In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before ...
Dec 06, 2009 |
5 / 5 (1) |
0
New cancer target for non-Hodgkin's lymphoma
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...
Nov 22, 2009 |
5 / 5 (1) |
0
Lymphoma
Lymphoma is a type of cancer that originates in lymphocytes of the immune system. They often originate in lymph nodes, presenting as an enlargement of the node (a tumor). Lymphomas are closely related to lymphoid leukemias, which also originate in lymphocytes but typically involve only circulating blood and the bone marrow (where blood cells are generated in a process termed haematopoesis) and do not usually form static tumours. There are many types of lymphomas, and in turn, lymphomas are a part of the broad group of diseases called hematological neoplasms.
Thomas Hodgkin published in 1832 the first description of lymphoma, specifically of the form named after him, Hodgkin's lymphoma. Since then many other forms of lymphoma have been described, grouped under several proposed classifications. The 1982 Working formulation classification became very popular. It introduced the category non-Hodgkin lymphoma (NHL), itself divided into 16 different diseases. However, since these different lymphomas have little in common with each other, the NHL label is of limited usefulness for doctors or patients and is slowly being abandoned. The latest classification by the WHO (2001) lists 43 different forms of lymphoma divided in four broad groups.
Some forms of lymphoma are indolent (e.g. small lymphocytic lymphoma), compatible with a long life even without treatment, whereas other forms are aggressive (e.g. Burkitt's lymphoma), causing rapid deterioration and death. The prognosis therefore depends on the correct classification of the disease, established by a pathologist after examination of a biopsy.
Although older classifications referred to histiocytic lymphomas, these are recognized in newer classifications as of B, T or NK cell lineage. True histiocytic malignancies are rare and are classified as sarcomas.
For more information about Lymphoma, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.